A Novel Drug for Borderline Personality Disorder
A Novel Drug for Borderline Personality Disorder
Recruiting · NCT02097706 · Registry updated 2025-08-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Novel Drug for Borderline Personality Disorder | Personality Disorders, borderline personality disorder, psychiatric disorder | Recruiting | Phase 2 | 2025-08-15 | NCT02097706 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The Alfred | 22 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Monash Alfred Psychiatry Research Centre | Melbourne | Australia | 3 |